An antigenic determinant common to the major capsid polypeptide (VP1) of simian virus 40 (SV40) and polyoma virus is described. Antisera prepared against intact viral particles reacted only with cells infected with the homologous virus by immunofluorescence tests (IF). However, antisera prepared against disrupted SV40 particles reacted in IF with both polyoma-and SV40-infected permissive cells. The cross-reaction with polyoma was localized to VP1 by the following evidence. (i) The IF cross-reaction was inhibited by preincubation of the antiserum with purified SV40 VP1; (ii) purified radiolabeled polyoma VP1 was precipitated by the cross-reactive serum, and this reaction was inhibited by unlabeled SV40 VP1; (iii) other antisera prepared against purified SV40 VP1 or polyoma VP1 reacted in IF with both SV40-and polyoma-infected permissive cells. These cross-reacting antisera also reacted in IF with permissive cells infected with BK virus, rabbit kidney vacuolating virus, and the stumptailed macaque virus, suggesting that all members of the polyoma-SV40 subgroup share a common antigenic determinant located in their major capsid polypeptides.
Papovaviruses of the simian virus 40 (SV40)-polyoma subgroup (1, 6, 15, 17, 18) occur in the mouse (polyoma virus and K virus), the rabbit (rabbit kidney vacuolating virus [RKV] ), the rhesus macaque (SV40), the stumptailed macaque (STMV), and humans (JC virus and BK virus -JCV and BKV). The primate papovaviruses SV40, JCV, and BKV are immunologically related as evidenced by a high level of cross-reactivity between their T antigens (20, 23, 25 ) and a minor cross-reactivity between antigens on the surface of their virions (6, 16) . No immunological relationships have been described between primate and nonprimate papovaviruses of this subgroup or between the different members of the nonprimate viruses.
In the course of immunological studies with STMV, the most recently recognized virus of this subgroup, we found that a high-titered antiserum to SV40 prepared by immunization with viral particles previously disrupted with sodium dodecyl sulfate (SDS) (14) was markedly cross-reactive in immunofluorescence (IF) tests with cells infected by STMV or polyoma virus. Since an antigenic relationship between SV40 and polyoma viruses had not been described previously, we investigated the extent and specificity of this cross-reactivity. The results reported here demonstrate that the major capsid protein of SV40, viral polypeptide 1 (VP1), shares an antigenic determinant with the major capsid protein of polyoma virus and further suggest that the same determinant is shared by other members of the subgroup.
MATERIALS AND METHODS
Viruses and cells. Papovaviruses were propagated in permissive cells as follows: SV40 (strain A 2895 from B. Eddy) in primary African green monkey kidney (AGMK) cells; BKV (strain BK [61) in WI-38 cells; STMV (strain Delta 3919 [18] ) in primary or early passage rhesus kidney cells; polyoma (large plaque virus, strain A2 from M. Fried [5] ) in mouse 3T3/D cells; and RKV (strain 443 from W. P. Rowe [7] ) in primary rabbit kidney cells. Small plaque SV40 (strain 776), used for preparation of SV40 VP1, was propagated in the BSC-1 line of AGMK cells.
Antisera prepared against unpurified viral particles. (i) Rhesus anti-SV40: 25 sera were obtained from 16 rhesus between 4 and 8 weeks after experimental infection with a single dose of SV40. These sera had high titers of neutralizing and low titers of T antibodies to SV40 (21 (18) .
Antiserum prepared against purified viral particles. Virions and empty capsids used for preparation of the serum described here and for the antiserum preparations described below were purified from crude lysate of virus-infected cells by repeated centrifugation to equilibrium in cesium chloride (14) . (i) Guinea pig antiserum to SV40 (G7) was prepared by D. Hoggan as previously described (14) . This antiserum was reactive by complement fixation (CF) with SV40 particles and capsomers, but not with individual capsid proteins after denaturation. It was not reactive with SV40 T antigen in IF or CF assays.
Antisera prepared against disrupted, purified viral particles. (i) Rabbit antiserum to empty SV40 capsids disrupted by SDS (R2) was prepared as previously described (14) . Three postinoculation sera were tested. Pool 1 was obtained after the initial course of immunization with three injections of 150
Ag each (in Freund adjuvant) of purified empty shells treated with SDS and mercaptoethanol. Pool 24 was subsequent to a booster injection of SDScapsid proteins intravenously 1 month later. Pool 31 was subsequent to a second booster injection of undisrupted SV40 empty shells 5 months later. All three pools were reactive by CF and radioisotope immunoprecipitation (RIP) tests with undisrupted virus, SDS-disrupted virus and purified VP1 and VP3 from acrylamide gels, and nonreactive to SV40 T antigen by CF tests (14, 24 ; H. L. Ozer, unpublished data).
(ii) Guinea pig antisera to SV40 capsids disrupted by pH 12.5 (G8 and G9) were prepared as described previously (14) . These sera were reactive by CF with undisrupted virus, SDS-disrupted virus, purified VP1 and VP3, and by IF with monkey cells infected by wild-type SV40 or tsBll, a mutant defective in virus assembly (24, 26) . They were not reactive with T antigen by CF or IF assays. Antisera prepared against purified major structural protein (VP1) of the virus. (i) Guinea pig anti-VP1 of SV40 (Gl and G2) was obtained by injecting two adult, female guinea pigs three times over a 5-month period with VP1 purified by acrylamide gel electrophoresis (in SDS). The sera were reactive with VP1 in CF tests (H. L. Ozer, unpublished data).
(ii) Rabbit antisera to VP1 of SV40 (CT1 and (20) were used as sources of the respective T antigens. Control antigens consisted of uninfected cells or cells infected with other viruses as described in the text. Antisera were diluted in phosphatebuffered saline (PBS), pH 7.2, in twofold steps. Fluorescein-labeled antibodies against human, rabbit, hamster, mouse, and guinea pig immunoglobulins were purchased from Meloy Laboratories (Springfield, Va.).
Inhibition of IF. Rabbit antiserum to SV40 SDScapsid protein (R2, pool 31) was tested for inhibition by SV40 VP1, purified by acrylamide electrophoresis. The reaction mixture containing 400 ,ul of VP1 (in 0.5% SDS), 120 ,ul of 5% bovine serum albumin, 100 jul of 1 M NaCl, and 50 /,u of a 1:5 dilution of the immune serum was incubated for 1 h at 37°C and overnight at room temperature. Subsequently, the volume was adjusted to 1 ml with PBS, which represented an initial serum dilution of 1:100.
Two controls used were an SDS control in which 400 ,ul of 0.5% SDS was substituted for SV40 VP1 and an untreated control in which 620 ,ul of PBS was added to the serum before incubation. The test and control sera were titrated against SV40-and polyoma-infected cells.
RIP. VPls of SV40 and polyoma were isolated from [35S]methionine-labeled purified virions after denaturation by SDS and electrophoresis on 12.5% polyacrylamide gels as described by Studier (22) . The viral proteins were identified after autoradiography (utilizing appropriate reference markers [13] ) and eluted in 0.5% SDS-0.01 M Tris-hydrochloride, pH 7.4. RIP tests were performed using rabbit antiserum to SDS-disrupted SV40 virions (R2, pool 31) as previously described (10, 24) with minor modifications.
Samples of [35S]VP1 were diluted to 50 gl in 0.01 M Tris, pH 7.4, 0.1 M NaCl, 6 mg of bovine serum albumin per ml, and 0.5% SDS and incubated for 60 min at 37°C with 5 ,ul of pool 31 of rabbit R2. Fifty microliters of sheep anti-rabbit gamma globulin was added, and the incubation was continued for an additional 60 min at 37°C. The precipitate was collected by centrifugation and washed three times with 0.1 M NaCl-0.01 M Tris-hydrochloride, pH 7.4. The precipitate was dissolved in 1% SDS and then assayed for radioactivity. The initial and threewash supernatants were pooled and assayed for radioactivity, and the fraction of radioactivity in the precipitate was calculated.
Hemagglutination inhibition tests. These were performed with guinea pig erythrocytes (19) (Table 1) . Thus, 25 SV40-immune rhesus sera from experimentally infected animals as well as a guinea pig and a rabbit serum against undisrupted SV40 particles had IF antibody titers ranging from 1:80 to 1:1,280 against the homologous SV40-infected monkey cells but were nonreactive with polyoma-infected mouse cells. Similarly, a rabbit and a mouse serum prepared by immunization with undisrupted polyoma virions had, respectively, titers of 1:320 and 1:80 against the homologous polyoma antigens, but both were nonreactive with SV40 antigens. These results confirmed the previously described lack of immunological cross-reactivity between SV40 and polyoma (12) in tests with conventionally prepared immune sera.
In contrast, sera prepared by immunization with disrupted SV40 virus particles were markedly cross-reactive with the heterologous polyoma virus-infected cells (Table 1) . Each ofthree serum pools of rabbit R2 immunized with SDSdisrupted empty shells and sera of both guinea pigs prepared against alkali-disrupted virions had high and comparable titers to both SV40 and polyoma antigens. The preimmunization serum of rabbit R2 was nonreactive to both antigens.
The IF staining of the cross-reactive sera was judged to be specific on the basis of the following evidence. The fluorescence was brilliant, nuclear, and sparing of nucleoli (Fig. 1) Serum R2, pool 31 had the highest crossreactive IF titers to polyoma virus-infected cells. Since this serum was prepared by immunization with disrupted viral particles, it contained antibodies to both SV40 VP1 and VP3 (14) . To determine whether the polyoma crossreactive antibodies in this serum were directed against SV40 VP1, the serum was preincubated with purified SV40 VP1 as described in Materials and Methods and then titrated against SV40 virus-and polyoma virus-infected cells. Incubation with SV40 VP1 markedly reduced the anti-SV40 IF titers of the serum (Table 2) , indicating that most of the antibodies in the serum detectable by IF were to SV40 VP1. More importantly, the treatment reduced the anti-polyoma titer of the serum from 1:3,200 to <1:100.
The cross-reactivity of serum R2, pool 31 to polyoma VP1 was also demonstrated by RIP tests. This serum was tested for its ability to precipitate 3S-labeled VP1 purified by SDSpolyacrylamide gel electrophoresis from SV40 or polyoma virions ( Table 3) . As expected, precipitation of the homologous antigen, SV40 VP1, was essentially complete. Under the conditions of the experiment, about one-half of the polyoma VP1 was precipitated. To demonstrate further that the precipitation of polyoma VP1 was due to an immunological cross-reaction, a competition experiment was carried out. Increasing quantities of unlabeled SV40 VP1 were mixed with a constant amount of
[S]polyoma VP1, and RIP tests were performed (Fig. 2) . The observed inhibition shows that antibodies that react with polyoma VP1 also react with SV40 VP1.
Pool 31 of rabbit R2 was examined for its ability to react with surface antigens of the polyoma virion by hemagglutination inhibition and immune electron microscopy tests. The serum (at a dilution of 1:20) failed to inhibit hemagglutination of guinea pig erythrocytes by 8 hemagglutinating units of polyoma virus. The results of immune electron microscopy tests with this serum, which have been described elsewhere (18) , showed that although the serum reacted very strongly with the homologous SV40 virions, it was completely nonreactive with polyoma virions. These findings suggest that the cross-reactive antibodies are directed toward an antigen not accessible on the polyoma virion surface and rule out the possibility that polyoma particles contaminated the SV40 preparations used for immunization.
IF reactivity of immune sera to other papovaviruses of the SV40-polyoma subgroup. IF tests were perforned to determine whether the immunological relationship observed between SV40 and polyoma extended to other viruses of the subgroup. Permissive cells infected with SV40, BKV, STMV, RKV, and polyoma viruses were reacted with pool 31 of rabbit R2, with rabbit serum CT-1 prepared against SV40 VP1, and rabbit serum SI prepared against polyoma VP1 (Table 4) . Each of these three sera was clearly cross-reactive, and to a comparable degree, against all the tested antigens. The IF staining of three of these antigens by pool 31 of rabbit R2 is illustrated in Fig. 1 . In contrast, rabbit antisera against BKV, STMV, RKV, and polyoma viruses prepared by immunization with undisrupted virions reacted only with the respective homologous antigens. The rabbit serum Rl prepared against undisrupted SV40 virions showed a minor, previously recognized (6) cross-reactivity with BKV antigen. These results suggest that the antigenic determinant which is common to SV40 and polyoma viruses is also shared by BKV, STMV, and RKV. (1,800 cpm), and the indicated quantity of SV40 VP1. Reaction with rabbit antiserum to SDS-disrupted SV40 particles (rabbit R2, pool 31) and precipitation with sheep anti-rabbit gamma globulin were performed as described in Materials and Methods. Symbols: 0, rabbit R2, pool 31; 0, normal rabbit serum.
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DISCUSSION
The experiments reported here demonstrate that SV40 and polyoma viruses share a common antigenic determinant(s) located in the major capsid polypeptide VP1. The common determinant was regularly expressed in virus-infected cells and was first detected by IF assays with rabbit serum prepared against SDS-disrupted SV40 particles (anti-SV40 [SDS] The immunological cross-reactivity observed between SV40 and polyoma viruses extends to other members of the SV40-polyoma subgroup of papovaviruses. Nuclear antigens in permissive cells infected with BKV, STMV, and RKV reacted strongly with sera against SV40 (SDS), SV40 VP1, and polyoma VP1 in IF tests. In contrast, sera prepared by immunization with intact viral particles reacted only with the homologous antigens, except for a minor crossreaction of the anti-SV40 serum with BKV antigens. These data do not directly demonstrate that the antigenic detenninants detected in BKV-, STMV-, and RKV-infected cells are identical with the antigenic determinant common to SV40 and polyoma, but this seems very likely. These results indicate a common evolutionary origin for viruses of the SV40-polyoma subgroup and suggest that sera against disrupted particles or against purified VP1 may be useful for identifying new viruses of this subgroup. We were unable to test whether K virus and JC virus also shared this common antigen because of a lack of readily available tissue culture systems to propagate these viruses.
The observation that sera prepared by immunization with viral polypeptides from SDS-disrupted virions have a broader reactivity than serum prepared by immunization with intact virions has also been reported in studies with adeno-associated virus (AAV). IF tests with antisera to viral polypeptides obtained from SDStreated human AAV type 3 virions revealed new immunological relationships between the human AAV types (8) . More recently, M. D. Hoggan (personal communication) has demonstrated cross-reactivity between AAV of different species by use of such antisera. These data together with our results suggest that the ability to induce antibodies to previously unrecognized antigenic determinants by using denatured polypeptides (as by SDS treatment) as immunogens may be valuable in the study of other systems.
